Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 25 Central Nervous System Stimulants.

Slides:



Advertisements
Similar presentations
Prescription Drugs. What is prescription drug abuse? Taking a prescription drug that is not prescribed for you, or taking it for reasons or in dosages.
Advertisements

Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introductory Clinical Pharmacology Chapter 39 Antiarrhythmic Drugs
Introduction to Clinical Pharmacology Chapter 33- Diuretics
Antiparkinsonian Agents Ch 14. Parkinson’s Disease Progressive, y.o. d/t imbalance between dopamine & acetylcholine Symptoms: Slowed movement.
Stimulants: Cocaine, Amphetamines, and Caffeine
Central Nervous Stimulants Classifications Analeptic Resp. Stimulant (Doxapram) Amphetamine (Dexadrine) Xanthine Derivatives Anorectic Agents (Sanorex,
Central Nervous System Stimulants and Related Drugs
CNS STIMULANTS SAMUEL AGUAZIM. What is the definition of a CNS stimulant? A CNS stimulant is a drug that increases motor activity, causes excitement and.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 04- The Nursing Process.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs.
 Chemical name: Methylphenidate  Brand name: Ritalin › Other brand names: Concerta, Methylin ER, Methadate ER and CD  Street names: › Vitamin R, Rids,
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 36 Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder.
Chapter 15 Respiration and Circulation. Factors That Can Alter Tissue Perfusion Cardiovascular Disease –Arteriosclerotic heart disease, hypertension,
Chapter 29 Central Nervous System Stimulants Used to Treat Attention Deficit Hyperactivity Disorder and Agents Used to Treat Alzheimer’s Disease.
And Alzheimer’s Disease
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 82 Drugs for Weight Loss.
ADHD and Psychopharmacology By Monica Robles M.D.
 Describe the actions, intended effects, and related nursing care for patients receiving CNS Stimulants.  Discuss the nursing process as it relates.
Stimulants By: Ginny Strother. What is a stimulant?  Stimulants are substances that stimulate the activity of the central nervous system. They increase.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 7 Penicillins.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 15 Antifungal Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 9 Tetracyclines, Macrolides, and Lincosamides.
1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 20 CENTRAL NERVOUS SYSTEM STIMULANTS.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 21 Anesthetic Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 17 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Drugs used in treatment of addiction
Rivastigmine Tartrate Presented by: Mona Abdulrahman Alkallabi Mona Abdulrahman Alkallabi.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 16 Antiparasitic Drugs.
By: Joseph Pepper, Sarah Coates, Chaniqua Jordan
Psychopharmacological interventions for ADHD Dr. Charles Pemberton, Ed.D, LPCC Manbeena Sekhon, Doctoral Student.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
Wendy McGurk.  Stimulants are a class of psychoactive drug that increases activity in the CNS  All major stimulants increase alertness, excitation,
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 16 Central Nervous System Stimulants and Related.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 22 Antianxiety Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 24 Antidepressant Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 23 Sedatives and Hypnotics.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 10 Fluoroquinolones and Aminoglycosides.
Chapter 29 Central Nervous System Stimulants Used to Treat Attention Deficit Hyperactivity Disorder and Agents Used to Treat Alzheimer’s Disease.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 11 Miscellaneous Anti-Infectives.
Stimulants Caffeine (most common), Ritalin, Adderall …
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 13 Leprostatic Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 31 Anticonvulsants.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder.
Drugs for Weight Loss 1.
The Central Nervous System
Central Nervous Stimulants
مقدمة: الاطفال الذين يعانون من كثرة النشاط الحركى ليسوا باطفال مشاغبين، او عديمين التربية لكن هم اطفال عندهم مشكلة مرضية لها تاثير سيء على التطور النفسى.
Hormone Secretion The thyroid gland secretes the hormones thyroxine (T4) and tri-iodothyronine (T3), which help to control metabolism. This process is.
CHEMISTRY MEDICINES AND DRUGS
Emotional and Mood Disorders chp. 16
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Introduction to Clinical Pharmacology Chapter 20 Antianxiety Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
CNS Stimulants: Action #1
CNS Stimulants.
CNS Stimulants Defination
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Cholinesterase Inhibitors: Actions and Uses
CNS Stimulants: Uses (p. 210)
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
CNS Stimulants: Action #1
Introduction to Sedatives and Hypnotics #1
Cholinergic Blocking Drugs: Actions
Introduction to Clinical Pharmacology Chapter 26 Cholinergic Drugs
Presentation transcript:

Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 25 Central Nervous System Stimulants

Copyright © 2008 Lippincott Williams & Wilkins. Medications to Recognize: CNS Stimulants Analeptics –Increase depth of respirations by stimulating receptors that measure amount of oxygen in blood Ex :Caffeine

Copyright © 2008 Lippincott Williams & Wilkins. CNS stimulants: Actions (cont’d) Amphetamines –Elevate blood pressure; wakefulness; increase or decrease pulse rate; produce euphoric state Ex: Adderall, methylphenidate (Ritalin) Anorexiants –Suppress appetite Ex: sibutramine (Meridia)

Copyright © 2008 Lippincott Williams & Wilkins. CNS Stimulants: Uses CNS stimulants as treatment for: –Attention deficit hyperactivity disorder; drug-induced respiratory depression; postanesthesia respiratory depression without reduction of analgesia; narcolepsy; sleep apnea; obesity; fatigue

Copyright © 2008 Lippincott Williams & Wilkins. CNS Stimulants: Adverse Reactions Neuromuscular reactions –Excessive CNS stimulation; headache; dizziness; apprehension; disorientation; hyperactivity Other –Nausea; vomiting; cough; dyspnea; urinary retention; tachycardia; palpitations

Copyright © 2008 Lippincott Williams & Wilkins. CNS Stimulants: Contraindications CNS stimulants contraindicated in patients with known hypersensitivity; convulsive disorders; ventilation mechanism disorders Nurse should not administer CNS stimulants to patients with cardiac problems; severe hypertension;

Copyright © 2008 Lippincott Williams & Wilkins. Nursing Process: Assessment Preadministration assessment –Respiratory depression Initial assessments: Blood pressure, pulse, respiratory rate Note depth of respirations and any pattern to respiratory rate Review recent laboratory test results

Copyright © 2008 Lippincott Williams & Wilkins. Nursing Process: Assessment Preadministration assessment (cont’d) –Attention deficit hyperactivity disorder Amphetamine prescribed: Weigh patient and take blood pressure, pulse, and respiratory rate Child with ADHD: Observe for patterns of abnormal behavior Record summary: Document/chart client’s behavior to provide comparison and help identify future changes

Copyright © 2008 Lippincott Williams & Wilkins. Nursing Process: Assessment Preadministration assessment (cont’d) –Obesity Anorexiant or amphetamine used for outpatient use Obtain and record blood pressure, pulse, respiratory rate, weight – before therapy starts and at each outpatient visit

Copyright © 2008 Lippincott Williams & Wilkins. Nursing Process: Implementation Monitoring and managing patient needs –Disturbed sleep patterns CNS stimulant therapy: Causes insomnia Avoid coffee, tea, cola drinks Administer during day time

Copyright © 2008 Lippincott Williams & Wilkins. Nursing Process: Evaluation Child’s behavior, school performance improve Weight loss is achieved Respiratory depression: Reversed Fewer episodes of inappropriate sleep patterns reported Adverse reactions are identified, reported, and managed

Copyright © 2008 Lippincott Williams & Wilkins. Nursing Process: Evaluation (cont’d) Patient complies with prescribed drug regimen Patient and family demonstrate understanding of drug regimen Patient verbalizes importance of complying with prescribed therapeutic regimen

Copyright © 2008 Lippincott Williams & Wilkins. End of Presentation